查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2030 年亚太地区类器官市场预测 - 区域分析 - 按器官类型、应用、来源和类型
市场调查报告书
商品编码
1402760

2030 年亚太地区类器官市场预测 - 区域分析 - 按器官类型、应用、来源和类型

Asia Pacific Organoids Market Forecast to 2030 - Regional Analysis - by Organ Type, Application, Source, and Type
出版日期: | 出版商: The Insight Partners | 英文 98 Pages | 订单完成后即时交付

价格

亚太类器官市场预计将从2022年的3.4124亿美元成长到2030年的18.6632亿美元。预计2022年至2030年CAGR为23.7%。

专注于药物发现活动推动亚太类器官市场

对新药和先进药物不断增长的需求正在推动药物发现和研究的整体步伐。根据 ClinicalTrials.gov 统计，2020 年临床试验研究总数估计为 356,282 项。休布雷希特研究所最近的一项调查表明，类器官可以透过识别不太可能从该药物中受益的患者来使昂贵的药物更具成本效益。全球范围内越来越多的临床试验预计将推动对先进医疗技术（包括类器官模型）的需求。

此外，药物发现中的类器官不仅限于癌症，它们还用于其他疾病，例如囊性纤维化、多囊性肾病变、小头畸形以及肠道和气道传染病。例如，类器官可以概括器官的特性，例如器官结构和功能。此外，类器官可以恢復组织或器官的原始遗传和表观遗传状态，使它们适合基因编辑。各种研究显示了将 CRISPR-Cas9 技术与类器官结合的积极成果，这为囊性纤维化的突破提供了更多机会。根据2020 年发表的一项研究“基于CRISPR 的腺嘌呤编辑器纠正囊性纤维化类器官生物库中的无义突变”，囊性纤维化类器官生物库代表了664 名患者，其中约20%理论上能够有效修復无义突变透过腺嘌呤碱基编辑器在囊性纤维化跨膜导体受体中。儘管基因编辑类器官在一些动物模型中取得了一些成果，但其效率明显较低，成功率不高。因此，研究和开发基因编辑类器官的安全性、长期稳定性和功能性的方法至关重要。

此外，COVID-19 大流行引发了开发人类肺类器官模型的需求。例如，MilliporeSigma 开发了 3dGRO 人类肺类器官培养系统，使研究人员能够控制、存取和复製器官组织，以培养人类肺上皮类器官模型，从而有助于在研究过程中获得积极和成功的结果。因此，此类创新预计将为市场成长提供更重要的成长机会。

亚太类器官市场概况

亚太类器官市场分为澳洲、中国、印度、日本、韩国和亚太其他地区。由于癌症发病率上升、对基因突变和癌症研究的需求不断增长、政府努力提高对人类类器官的认识、支持性法规等因素，该地区的市场在预测期内可能会继续以最快的速度增长用于先进人类类器官产品的开发和商业化，并增加对类器官研究的资助。

亚太类器官市场收入及 2030 年预测（百万美元）

亚太地区类器官市场细分

亚太类器官市场按器官类型、应用类型、来源和国家进行细分。

依器官类型，亚太类器官市场分为肠、肝、胃、胰臟、肺、脑、肾等。 2022 年，肠道领域在亚太类器官市场中占最大份额。

根据类型，亚太类器官市场分为仪器、消耗品和服务。 2022 年，消耗品领域在亚太类器官市场中占据最大份额。

根据应用，亚太类器官市场分为发育生物学疾病、传染病病理学、再生医学、药物毒性和功效测试、药物发现和个人化医疗等。 2022 年，发育生物学疾病领域在亚太类器官市场中占据最大份额。

根据来源，亚太类器官市场分为多能干细胞和器官特异性成体干细胞。 2022 年，多能干细胞细分市场在亚太类器官市场中占有更大份额。

根据国家/地区，亚太类器官市场分为日本、中国、澳洲、印度、韩国和亚太其他地区。 2022 年，日本在亚太类器官市场占据主导地位。

Cellesce、Corning Inc、InSphero、Merck KGaA、STEMCELL Technologies Inc 和 Thermo Fisher Scientific Inc 是亚太类器官市场上的一些领先公司。

目录

第 1 章：简介

  • Insight Partners 研究报告指南
  • 市场区隔

第 2 章：执行摘要

  • 亚太地区关键见解
  • 亚太市场吸引力

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：亚太地区类器官市场格局

  • 概述
  • 亚太地区 PEST 分析

第 5 章：亚太地区类器官市场 - 主要产业动态

  • 主要市场驱动因素：
    • 对肿瘤建模和生物样本库的需求不断增加
    • 越来越多地采用个人化药物
    • 人们日益关注开发动物测试模型的替代方案
  • 主要市场限制：
    • 与将类器官纳入现有工作流程相关的问题
    • 缺乏熟练的专业人员
  • 主要市场机会：
    • 专注于药物发现活动
  • 未来的趋势：
    • 将类器官与器官晶片结合
  • 影响分析：

第 6 章：类器官市场 - 亚太市场分析

  • 亚太地区类器官市场收入，2022 - 2030

第 7 章：亚太地区类器官市场 - 收入和 2030 年预测 - 按类型

  • 概述
  • 2022 年及 2030 年亚太地区类器官市场收入份额，依器官类型划分 (%)
  • 胃
  • 肠
  • 肝
  • 胰臟
  • 肺
  • 脑
  • 肾
  • 其他的

第 8 章：亚太地区类器官市场 - 2030 年收入与预测 -按应用

  • 概述
  • 2022 年及 2030 年亚太地区类器官市场收入份额（按应用划分）（%）
  • 发育生物学
  • 传染病的疾病病理学
  • 再生医学
  • 药物毒性和药效测试
  • 药物发现与个人化医疗
  • 其他的

第 9 章：亚太地区类器官市场 - 收入和 2030 年预测 - 按来源

  • 概述
  • 2022 年及 2030 年亚太地区类器官市场收入份额（按来源划分）（%）
  • 多能干细胞
  • 器官特异性成体干细胞

第 10 章：亚太类器官市场 - 收入和 2030 年预测 - 按类型

  • 概述
  • 2022 年和 2030 年亚太地区类器官市场收入份额，按类型划分 (%)
  • 仪器
  • 耗材
  • 服务

第 11 章：亚太地区类器官市场 - 国家分析

    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区

第 12 章：COVID-19 前后的影响

  • COVID-19 前后的影响

第 13 章：亚太类器官市场产业格局

  • 概述
  • 市场上公司采取的成长策略，(%)
  • 有机发展
    • 概述
  • 无机发展
    • 概述

第 14 章：亚太地区类器官市场、主要公司概况

  • STEMCELL Technologies Inc.
  • Cellesce Ltd
  • Thermo Fisher Scientific Inc
  • Corning Inc
  • Merck KGaA
  • InSphero

第 15 章：附录

  • 关于我们
  • 专业术语
Product Code: TIPRE00018852

The Asia Pacific organoids market is expected to grow from US$ 341.24 million in 2022 to US$ 1,866.32 million by 2030. It is estimated to grow at a CAGR of 23.7% from 2022 to 2030.

Focus on Drug Discovery Activities Fuel the Asia Pacific Organoids Market

The increasing demand for new and advanced drugs is driving the overall pace of drug discovery and research. According to ClinicalTrials.gov, the total number of clinical trial studies in 2020 was estimated to be 356,282. A recent survey by the Hubrecht Institute states that organoids can potentially make expensive drugs more cost-effective by identifying patients who are not likely to benefit from the drug. An increasing number of clinical trials worldwide is expected to drive the demand for advanced medical technologies, including organoid models.

Further, organoids in drug discovery are not limited to just cancer, they are also used in other diseases, such as cystic fibrosis, polycystic kidney disease, microcephaly, and infectious diseases of the gut and airway. For instance, organoids can summarize the properties of an organ, such as organ structure and function. Also, organoids can restore a tissue or organ's original genetic and epigenetic state, making them suitable for gene editing. Various studies have shown positive results of combining CRISPR-Cas9 technology with organoids, which has expanded opportunities for breakthroughs in cystic fibrosis. According to a study 'CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank,' published in 2020, a biobank of cystic fibrosis intestinal organoids represented 664 patients, and ~20% of them were theoretically able to efficiently repair nonsense mutations in the cystic fibrosis transmembrane conductor receptor through adenine base editors. Despite a few achievements of gene-edited organoids in some animal models, their efficiency is significantly low, and the success rate is not high. Therefore, it is crucial to research and develop a process for gene-edited organoids' safety, long-term stability, and functionality.

Moreover, the COVID-19 pandemic triggered the need to develop human lung organoid models. For instance, MilliporeSigma developed a 3dGRO Human Lung Organoid Culture System that allows researchers to control, access, and reproduce organ tissue for culturing an organoid model of human lung epithelium that can aid in obtaining positive and successful results during their research. Thus, such innovations are expected to offer more significant growth opportunities for the market growth.

Asia Pacific Organoids Market Overview

The Asia Pacific organoids market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. The market in the region is likely to continue to grow at the fastest rate during the forecast period owing to factors such as increasing incidences of cancer, growing demand for gene mutation and cancer research, government efforts to raise awareness related to human organoids, supportive regulations for the development and commercialization of advanced human organoids products, and increased funding for organoids research.

Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Organoids Market Segmentation

The Asia Pacific organoids market is segmented into organ type, type application, source, and country.

Based on organ type, the Asia Pacific organoids market is segmented into intestine, liver, stomach, pancreas, lung, brain, kidney, and others. The intestine segment held the largest share of the Asia Pacific organoids market in 2022.

Based on type, the Asia Pacific organoids market is segmented into instruments, consumables, and services. The consumables segment held the largest share of the Asia Pacific organoids market in 2022.

Based on application, the Asia Pacific organoids market is segmented into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment held largest share of the Asia Pacific organoids market in 2022.

Based on source, the Asia Pacific organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cell. The pluripotent stem cells segment held a larger share of the Asia Pacific organoids market in 2022.

Based on country, the Asia Pacific organoids market is segmented into the Japan, China, Australia, India, South Korea, and the Rest of Asia Pacific. Japan dominated the Asia Pacific organoids market in 2022.

Cellesce, Corning Inc, InSphero, Merck KGaA, STEMCELL Technologies Inc, and Thermo Fisher Scientific Inc are some of the leading companies operating in the Asia Pacific organoids market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific organoids market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific organoids market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Asia Pacific Key Insights
  • 2.2 Asia Pacific Market Attractiveness

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Organoids Market Landscape

  • 4.1 Overview
  • 4.2 Asia Pacific PEST Analysis

5. Asia Pacific Organoids Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Increasing Demand for Tumor Modeling and Biobanking
    • 5.1.2 Growing Adoption of Personalized Drugs
    • 5.1.3 Rising Focus on Developing Alternatives for Animal Testing Models
  • 5.2 Key Market Restraints:
    • 5.2.1 Issues Related to Incorporation of Organoids into Existing Workflows
    • 5.2.2 Dearth of Skilled Professionals
  • 5.3 Key Market Opportunities:
    • 5.3.1 Focus on Drug Discovery Activities
  • 5.4 Future Trends:
    • 5.4.1 Combining Organoid with Organ-On-A-Chip
  • 5.5 Impact Analysis:

6. Organoids Market - Asia Pacific Market Analysis

  • 6.1 Asia Pacific Organoids Market Revenue (US$ Mn), 2022 - 2030

7. Asia Pacific Organoids Market - Revenue and Forecast to 2030 - by Type

  • 7.1 Overview
  • 7.2 Asia Pacific Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
  • 7.3 Stomach
    • 7.3.1 Overview
    • 7.3.2 Stomach: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Intestine
    • 7.4.1 Overview
    • 7.4.2 Intestine: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Liver
    • 7.5.1 Overview
    • 7.5.2 Liver: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Pancreas
    • 7.6.1 Overview
    • 7.6.2 Pancreas: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Lung
    • 7.7.1 Overview
    • 7.7.2 Lung: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Brain
    • 7.8.1 Overview
    • 7.8.2 Brain: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.9 Kidney
    • 7.9.1 Overview
    • 7.9.2 Kidney: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.10 Others
    • 7.10.1 Overview
    • 7.10.2 Others: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Organoids Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 Asia Pacific Organoids Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Developmental Biology
    • 8.3.1 Overview
    • 8.3.2 Developmental Biology: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Disease Pathology of Infectious Disease
    • 8.4.1 Overview
    • 8.4.2 Disease Pathology of Infectious Disease: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Regenerative Medicine
    • 8.5.1 Overview
    • 8.5.2 Regenerative Medicine: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Drug Toxicity and Efficacy Testing
    • 8.6.1 Overview
    • 8.6.2 Drug Toxicity and Efficacy Testing: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Drug Discovery and Personalized Medicine
    • 8.7.1 Overview
    • 8.7.2 Drug Discovery and Personalized Medicine: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Organoids Market - Revenue and Forecast to 2030 - by Source

  • 9.1 Overview
  • 9.2 Asia Pacific Organoids Market Revenue Share, by Source 2022 & 2030 (%)
  • 9.3 Pluripotent Stem Cells
    • 9.3.1 Overview
    • 9.3.2 Pluripotent Stem Cells: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Organ-specific Adult Stem Cells
    • 9.4.1 Overview
    • 9.4.2 Organ-specific Adult Stem Cells: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Organoids Market - Revenue and Forecast to 2030 - by Type

  • 10.1 Overview
  • 10.2 Asia Pacific Organoids Market Revenue Share, by Type 2022 & 2030 (%)
  • 10.3 Instruments
    • 10.3.1 Overview
    • 10.3.2 Instruments: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Consumables
    • 10.4.1 Overview
    • 10.4.2 Consumables: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Services
    • 10.5.1 Overview
    • 10.5.2 Services: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)

11. Asia Pacific Organoids Market - Country Analysis

  • 11.1 Asia Pacific Organoids Market, Revenue and Forecast to 2030
    • 11.1.1 Overview
    • 11.1.2 Asia Pacific Organoids Market by Country
      • 11.1.2.1 China
        • 11.1.2.1.1 Overview
        • 11.1.2.1.2 China Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.2.1.3 China Organoids Market, by Organ Type
        • 11.1.2.1.4 China Organoids Market, by Application
        • 11.1.2.1.5 China Organoids Market, by Source
        • 11.1.2.1.6 China Organoids Market, by Type
      • 11.1.2.2 Japan
        • 11.1.2.2.1 Overview
        • 11.1.2.2.2 Japan Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.2.2.3 Japan Organoids Market, by Organ Type
        • 11.1.2.2.4 Japan Organoids Market, by Application
        • 11.1.2.2.5 Japan Organoids Market, by Source
        • 11.1.2.2.6 Japan Organoids Market, by Type
      • 11.1.2.3 India
        • 11.1.2.3.1 Overview
        • 11.1.2.3.2 India Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.2.3.3 India Organoids Market, by Organ Type
        • 11.1.2.3.4 India Organoids Market, by Application
        • 11.1.2.3.5 India Organoids Market, by Source
        • 11.1.2.3.6 India Organoids Market, by Type
      • 11.1.2.4 Australia
        • 11.1.2.4.1 Overview
        • 11.1.2.4.2 Australia Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.2.4.3 Australia Organoids Market, by Organ Type
        • 11.1.2.4.4 Australia Organoids Market, by Application
        • 11.1.2.4.5 Australia Organoids Market, by Source
        • 11.1.2.4.6 Australia Organoids Market, by Type
      • 11.1.2.5 South Korea
        • 11.1.2.5.1 Overview
        • 11.1.2.5.2 South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.2.5.3 South Korea Organoids Market, by Organ Type
        • 11.1.2.5.4 South Korea Organoids Market, by Application
        • 11.1.2.5.5 South Korea Organoids Market, by Source
        • 11.1.2.5.6 South Korea Organoids Market, by Type
      • 11.1.2.6 Rest of Asia Pacific
        • 11.1.2.6.1 Overview
        • 11.1.2.6.2 Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.2.6.3 Rest of Asia Pacific Organoids Market, by Organ Type
        • 11.1.2.6.4 Rest of Asia Pacific Organoids Market, by Application
        • 11.1.2.6.5 Rest of Asia Pacific Organoids Market, by Source
        • 11.1.2.6.6 Rest of Asia Pacific Organoids Market, by Type

12. Pre & Post COVID-19 Impact

  • 12.1 Pre & Post COVID-19 Impact

13. Asia Pacific Organoids Market Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies Done by the Companies in the Market, (%)
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.4 Inorganic Developments
    • 13.4.1 Overview

14. Asia Pacific Organoids Market, Key Company Profiles

  • 14.1 STEMCELL Technologies Inc.
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Cellesce Ltd
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Thermo Fisher Scientific Inc
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Corning Inc
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Merck KGaA
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 InSphero
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments

15. Appendix

  • 15.1 About Us
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Organoids Market Segmentation
  • Table 2. China Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 3. China Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 4. China Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 5. China Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 6. Japan Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 7. Japan Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 8. Japan Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 9. Japan Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 10. India Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 11. India Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 12. India Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 13. India Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 14. Australia Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 15. Australia Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 16. Australia Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 17. Australia Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 18. South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 19. South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 20. South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 21. South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 22. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn) -Organ Type
  • Table 23. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 24. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn) Source
  • Table 25. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 26. Organic Developments Done by Companies
  • Table 27. Inorganic Developments Done by Companies
  • Table 28. Glossary of Terms, Asia Pacific Organoids Market

List Of Figures

  • Figure 1. Asia Pacific Organoids Market Segmentation, By Country
  • Figure 2. Asia Pacific - PEST Analysis
  • Figure 3. Asia Pacific Organoids Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Asia Pacific Organoids Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Asia Pacific Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
  • Figure 7. Stomach: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Intestine: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Liver: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Pancreas: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Lung: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Brain: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Kidney: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Others: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Asia Pacific Organoids Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 16. Developmental Biology: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Disease Pathology of Infectious Disease: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Regenerative Medicine: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Drug Toxicity and Efficacy Testing: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Drug Discovery and Personalized Medicine: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Others: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Asia Pacific Organoids Market Revenue Share, by Source 2022 & 2030 (%)
  • Figure 23. Pluripotent Stem Cells: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Organ-specific Adult Stem Cells: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Asia Pacific Organoids Market Revenue Share, by Type 2022 & 2030 (%)
  • Figure 26. Instruments: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Consumables: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Services: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Asia Pacific Organoids Market, By Country -Revenue (2022) ($Mn)
  • Figure 30. Asia Pacific Organoids Market, By Key Countries, 2022 And 2030 (%)
  • Figure 31. China Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 32. Japan Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 33. India Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 34. Australia Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 35. South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 36. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 37. Pre & Post COVID-19 Impact
  • Figure 38. Growth Strategies Done by the Companies in the Market, (%)